Infinion Biopharma Limited - Company Profile

Q: Who are the current directors of Infinion Biopharma Limited?

The current directors of Infinion Biopharma Limited are Pankaj Kumar Singh, Shivani Pathak, Gautam Bali, Vishal Harshvardhan Jain, Dhruv Desai.

It is a life sciences public limited company based in Ahmedabad, Gujarat, India, established in 2018.

2018 Ahmedabad, Gujarat, India Active

Last Updated: December 29, 2025

Access Report

About Infinion Biopharma Limited

Infinion Biopharma Limited, a active public limited company, was established on 16 January 2018 in Ahmedabad, Gujarat, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U51909GJ2018PLC100571. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹17.50 Cr and a paid-up capital of ₹10.59 Cr.

Formerly known as Infinion Biopharma Private Limited, Glia Biopharmaceutical Private Limited. Its leadership includes Pankaj Kumar Singh (Director), Gautam Bali (Director), Vishal Harshvardhan Jain (Director). Past directors included Pankaj Kumar Singh, Ram Kishankumar Shah, Niraliben Lalitbhai Solanki. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 407, Silver Radiance, Pakwan Char Rasta, Sindhu Bhavan Road, B, Odakdev, Ahmedabad, Gujarat, 380054.

Company Details

CIN/LLPIN
U51909GJ2018PLC100571
Registration Number
100571
Incorporation Date
16 January 2018
Authorized Capital
₹17.50 Cr
Paid-Up Capital
₹10.59 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 17.50 Cr as on 29-12-2025
Paid Up Capital ₹ 10.59 Cr as on 29-12-2025
Company Age 8 Year, 1 Month
Last Filing with ROC 31 Mar 2024
Revenue Growth **** 1068.79% (FY 2023)
Profit Growth **** 3927.62% (FY 2023)
Ebitda **** 70.44% (FY 2023)
Net Worth 33.60% (FY 2023)
Total Assets **** 35.25% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Infinion Biopharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Infinion Biopharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Pankaj Kumar Singh	Director	30 Sep 2019	Current
Gautam Bali	Director	25 Jul 2018	Current
Vishal Harshvardhan Jain	Director	10 Mar 2018	Current
Dhruv Desai	Managing Director	07 Sep 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	04 Jun 2021	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Director	26 Jul 2022	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Director	27 Nov 2020	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Infinion Biopharma.

Infinion Biopharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1068.79% increase. The company also saw a substantial improvement in profitability, with a 3927.62% increase in profit. The company's net worth Soared by an impressive increase of 33.6%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1068.79%

*******

Revenue from Operations

*******

Total Assets

*******

35.25%

*******

Profit or Loss

*******

3927.62%

*******

Net Worth

*******

33.60%

*******

EBITDA

*******

70.44%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Infinion Biopharma?

In 2023, Infinion Biopharma had a promoter holding of 76.22% and a public holding of 23.77%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Infinion Biopharma?

Unlock and access historical data on people associated with Infinion Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Infinion Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infinion Biopharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Infinion Biopharma

Recent Activity within the Organization

Director Appointment

Progress on Dhruv Desai was appointed as a Managing Director was appointed as a Managing Director on 07 Sep 2025 & has been associated with this company since 5 months 13 days . was documented.
07 Sep 2025
Annual General Meeting

Progress on Infinion Biopharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
30 Sep 2024
Director Appointment

Shivani Pathak was appointed as a Company Secretary was appointed as a Company Secretary on 09 Sep 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
09 Sep 2024
Balance Sheet

Progress on Infinion Biopharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
31 Mar 2024
Director Appointment

Progress on Pankaj Kumar Singh was appointed as a Director was appointed as a Director on 30 Sep 2019 & has been associated with this company since 6 years 4 months . was documented.
30 Sep 2019
Director Appointment

Gautam Bali was appointed as a Director was appointed as a Director on 25 Jul 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
25 Jul 2018

Explore recent activity and updates - View Recent Activity